Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    51,127.18
    -638.72 (-1.23%)
     
  • CMC Crypto 200

    1,331.95
    -64.59 (-4.62%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Humana (HUM), Curant Health Team Up to Aid Chronic Patients

Humana Inc. HUM formed an alliance with Curant Health for enhancing the health experiences of Humana members who are suffering Chronic Heart Failure and Chronic Obstructive Pulmonary Disease.

This new pilot program intends to increase medication adherence to enable patients to lead better lives as well as decrease medical expenses.

Humana members with complicated health conditions will now leverage comprehensive support from this unique tie-up. Curant Health is a Medication Care Management organization with expertise in high-touch clinical aid for patients with chronic conditions.

This deal focuses on curbing adverse drug reactions, thereby lowering the need for hospital admissions. Both companies are committed to offer a better member experience.

This only helps the company utilize Curant Health’s innovative approach to customize patient care and data-driven insights that eventually facilitates the intake of prescription medicines.

This is not the first time that the health insurer took steps to ensure patient safety.

In July, Humana entered into a multi-year tie-up with Montefiore, one of New York’s premier academic health systems, to provide its Medicare Advantage members with access to the health system’s in-network medical care. The leading health insurer forged this partnership to widen the availability of the top-notch healthcare facilities among its current and future members.

In a year's time, the stock has gained 5.8%, underperforming its industry's growth of 33.2%. However, its series of acquisitions and dispositions, efficient capital deployment and a strong Medicare business position it for long-term gains. The company’s Medicaid business has also been contributing to its top line for years now on the back of contract wins.

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

ADVERTISEMENT

The company presently holds a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Other companies in the same space, such as The Joint Corp. JYNT, Molina Healthcare, Inc. MOH and UnitedHealth Group Incorporated UNH have also surged 473.3%, 52.9% and 38.4% in the same time frame.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report

Humana Inc. (HUM) : Free Stock Analysis Report

Molina Healthcare, Inc (MOH) : Free Stock Analysis Report

The Joint Corp. (JYNT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research